Ethics & Compliance Programs: A Strategic Business Driver for the Global Pharmaceutical Industry

January 01, 2016

In today’s global pharmaceutical industry, the need for mature ethics and compliance programs has transitioned from a system of standalone checks and balances to an integrated business strategy that leaders around the world expect. In an industry where public perception of ethics is among the lowest with constant scrutiny from global regulators, this transition was made out of necessity. During this session, Darren Jones (BSBA ’00), Partner, Polaris, discusses the very real and unique business drivers that create complex bribery and corruption risks, as well as how routine business activities have been adapted to create efficient business controls. 

To view the recording, visit here.

To learn more, please contact Darren Jones at: